Brazil’s Health Council Wants Patents for Three AIDS Drugs Broken

Brazil’s National Health Council sent Thursday, August 11, a document to the Brazilian Minister of Health recommending he breaks the patents – by compulsory licensing – of three AIDS medications: Lopinavir/Ritonavir, known as Kaletra, Efavirenz, and Tenofovir.

The Brazilian government spends around US$ 335 million (800 million reais) on these drugs every year.


The resolution, which was approved unanimously by the 20 members of the Council, also advises breaking off negotiations with the pharmaceutical laboratories that manufacture these medications.


The Ministry has been trying to reach agreements with these companies for at least two years. A capsule of Kaletra currently costs Brazil US$ 1.17 (2.73 reais, at today’s exchange rate). If the drug were produced here, it would cost US$ 0.41 (0.95 reais).


The Council also proposes that local production be initiated. At present, Brazilian laboratories are already manufacturing eight types of anti-retroviral drugs.


These drugs, together with nine imported medications, are distributed to the six countries that have AIDS treatment agreements with Brazil: Cape Verde, Guinea-Bissau, São Tomé and Prí­ncipe, East Timor, Bolivia, and Paraguay.


The average annual cost per patient is around US$ 2,500. Brazil has 163,000 anti-retroviral users.


The authorization of compulsory licensing is permitted by Brazilian law when it is a question of health, nutrition, environmental defense, or the country’s technological or socioeconomic development.


According to the government, the right is guaranteed by Article 71 of the Brazilian Patent Law (9279/96), Executive Decrees 3201/99 and 4830/03, the international Trips Agreement (Agreement on Trade-Related Aspects of Intellectual Property Rights), and the Doha Declaration, which applies the Trips to matters of public health.


Agência Brasil

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Brazil’s Daniela Mercury and NY’s Orchard Seal It with a Song Deal

The Orchard, a company specialized in distributing and marketing independent music, announced that it ...

Petrobras: from 23rd to 4th – Lula Gets His Piece of Flesh

The consulting company on energy, PFC, brought to public official results of an analysis ...

Politicking on Independence Day in Brazil

7 September is Brazilian National Day, the occasion when Dom Pedro declared his independence ...

What Will Happen to Brazil’s Astronaut Program? Brazil Doesn’t Know.

The president of Brazil’s Space Agency (Agência Espacial Brasileira) (AEB), Sergio Gaudenzi, says the ...

Brazil: Seeing Dollar Signs

Brazilian banks are betting in a growing economy for 2004. At the same time, ...

US Firm to Sell Cashew, Açaí­ and Other Brazilian Juices in US and Asia

Tropical Beverage, a producer and distributor of value-added water-based products, announced today, July 19, ...

International Passengers Arriving in Brazil Up 8%

The Brazilian Airport Infrastructure Company (Infraero) recorded 560,000 passengers who arrived in Brazil on ...

Transoceanic Highway Brings Asia Much Closer to Brazil

Brazilian President Luiz Inácio Lula da Silva, speaking in Puerto Maldonado, Peru, yesterday, for ...

Lula Readies Truth Committee Bill to Punish Torturers from Brazil’s Dictatorship

Brazil is seriously considering naming a "truth committee" a quarter of a century after ...

Brazil’s Year Surplus Grows to US$ 22.1 Billion

Brazil’s net government debt stood at US$ 327.9 billion (941.3 billion reais) in August, ...